Maria L Padilla MD
Critical Care Medicine, Pleural Disease, Sleep Medicine
Professor Medicine, Pulmonary, Critical Care and Sleep Medicine - Mount Sinai
Join to View Full Profile
5 E 98th StMt Sinai Med Ctr, Div PulmonologyNew York, NY 10029
Phone+1 212-241-5656
Fax+1 212-241-8866
Dr. Padilla is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Icahn School of Medicine at Mount Sinai/Mount Sinai HospitalFellowship, Pulmonary Disease and Critical Care Medicine, 1978 - 1980- Icahn School of Medicine at Mount Sinai/Mount Sinai HospitalResidency, Internal Medicine, 1975 - 1978
- Icahn School of Medicine at Mount SinaiClass of 1975
Certifications & Licensure
NY State Medical License 1976 - 2026
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Pulmonary Disease
Awards, Honors, & Recognition
- America's Top Doctors Castle Connolly, 2012-2014
- Top Doctors: New York Metro Area Castle Connolly, 2002-2014
- New York Magazine: Top Doctors Castle Connolly, 2003, 2006-2009, 2011-2012, 2014
- Join now to see all
Clinical Trials
- Evaluating the Effectiveness of Prednisone, Azathioprine, and N-acetylcysteine in Patients With IPF Start of enrollment: 2009 Oct 01
- Study to Assess the Efficacy and Safety of Simtuzumab (GS-6624) in Adults With Idiopathic Pulmonary Fibrosis (IPF) Start of enrollment: 2013 Jan 31
- The Study of the Use of Nintedanib in Slowing Lung Disease in Patients With Fibrotic or Non-Fibrotic Interstitial Lung Disease Related to COVID-19 Start of enrollment: 2020 Nov 18
- Join now to see all
Publications & Presentations
PubMed
- Early nintedanib deployment in COVID-19 interstitial lung disease (ENDCOV-I): study protocol of a randomised, double-blind, placebo-controlled trial.Valeria Santibanez, Aditi Mathur, Jigna Zatakia, Nicole Ng, Michele Cohen
BMJ Open Respiratory Research. 2025-04-10 - Unlocking disease insights to facilitate drug development: Pharmaceutical industry-academia collaborations in inflammation and immunology.Elena Peeva, Emma Guttman-Yassky, Yuji Yamaguchi, Brian Berman, Barry Oemar
Drug Discovery Today. 2025-03-01 - Late to the Game: Cancer Screening Guidelines and Nodule Surveillance in Idiopathic Interstitial Pneumonias.Valeria Santibanez, Mary Salvatore, Maria Padilla
American Journal of Respiratory and Critical Care Medicine. 2024-08-15
Grant Support
- Use of the Src Family Kinase Inhibitor Saracatinib in the Treatment of Pulmonary FibrosisNATIONAL JEWISH HEALTH2018–2025
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
